多功能人眼黑素皮质素系统
综述阐述α-促黑素细胞激素(α-MSH)经黑素皮质素受体(MC1R至MC5R)及受体辅助蛋白维持眼免疫特权,并参与角膜、视网膜、脉络膜等多组织功能调控;靶向MC1R、MC3R、MC4R和/或MC5R而不作用于肾上腺MC2R的黑素皮质素肽类,较ACTH类制剂全身不良反应更少,有望作为非甾体替代用于非感染性葡萄膜炎和干眼病。
要点
- α-MSH由虹膜、睫状上皮和视网膜色素上皮分泌,分布于前房房水和玻璃体,帮助维持眼免疫特权。
- 黑素皮质素系统参与维持角膜透明与免疫特权、调节泪液分泌、维持血-视网膜屏障及视网膜神经保护。
- 靶向MC1R、MC3R、MC4R和/或MC5R而不作用于肾上腺MC2R的肽类诱导皮质类固醇生成极少,全身不良反应较少。
核心结论
- 黑素皮质素系统在眼组织中有广泛的生理与疾病相关作用,靶向黑素皮质素受体的肽类有望作为非甾体替代用于非感染性葡萄膜炎和干眼病等炎症性眼病,并在角膜移植和糖尿病视网膜病变中具有转化应用前景。
研究设计与样本
- 本文为综述,汇总黑素皮质素系统在人眼组织中的生理与疾病相关作用及受体靶向肽类的应用前景。
主要发现
- α-MSH通过结合并激活黑素皮质素受体(MC1R至MC5R)及受体辅助蛋白(MRAPs)发挥作用,后者与拮抗剂协同构成黑素皮质素系统。
- α-MSH通过帮助抑制性免疫细胞发育和激活调节性T细胞,在维持眼免疫特权中起重要作用。
- 黑素皮质素系统参与维持角膜透明与免疫特权(限制角膜(淋巴)血管生成)、维持角膜上皮完整性、保护角膜内皮并可能提高角膜移植存活率。
- 黑素皮质素系统调节房水性泪液分泌(与干眼病相关)、通过维持血-视网膜屏障促进视网膜稳态、提供视网膜神经保护并控制脉络膜和视网膜异常新生血管生长。
- 与ACTH相比,靶向MC1R、MC3R、MC4R和/或MC5R而不作用于肾上腺MC2R的黑素皮质素肽类诱导皮质类固醇生成极少,全身不良反应较少。
临床怎么用
- 作者指出,靶向MC1R、MC3R、MC4R和/或MC5R的黑素皮质素受体靶向肽类有望作为非甾体替代用于非感染性葡萄膜炎和干眼病等炎症性眼病。
- 作者指出,黑素皮质素受体靶向肽类在促进眼稳态方面具有转化应用前景,例如角膜移植和糖尿病视网膜病变。
局限性
- 黑素皮质素信号在葡萄膜黑素细胞黑素生成中的作用与已确立的皮肤黑素生成作用相比仍不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune privilege in the eye involves physical barriers, immune regulation and secreted proteins that together limit the damaging effects of intraocular immune responses and inflammation. The neuropeptide alpha-melanocyte stimulating hormone (α-MSH) normally circulates in the aqueous humour of the anterior chamber and the vitreous fluid, secreted by iris and ciliary epithelium, and retinal pigment epithelium (RPE). α-MSH plays an important role in maintaining ocular immune privilege by helping the development of suppressor immune cells and by activating regulatory T-cells. α-MSH functions by binding to and activating melanocortin receptors (MC1R to MC5R) and receptor accessory proteins (MRAPs) that work in concert with antagonists, otherwise known as the melanocortin system. As well as controlling immune responses and inflammation, a broad range of biological functions is increasingly recognised to be orchestrated by the melanocortin system within ocular tissues. This includes maintaining corneal transparency and immune privilege by limiting corneal (lymph)angiogenesis, sustaining corneal epithelial integrity, protecting corneal endothelium and potentially enhancing corneal graft survival, regulating aqueous tear secretion with implications for dry eye disease, facilitating retinal homeostasis via maintaining blood-retinal barriers, providing neuroprotection in the retina, and controlling abnormal new vessel growth in the choroid and retina. The role of melanocortin signalling in uveal melanocyte melanogenesis however remains unclear compared to its established role in skin melanogenesis. The early application of a melanocortin agonist to downregulate systemic inflammation used adrenocorticotropic hormone (ACTH)-based repository cortisone injection (RCI), but adverse side effects including hypertension, edema, and weight gain, related to increased adrenal gland corticosteroid production, impacted clinical uptake. Compared to ACTH, melanocortin peptides that target MC1R, MC3R, MC4R and/or MC5R, but not adrenal gland MC2R, induce minimal corticosteroid production with fewer adverse systemic effects. Pharmacological advances in synthesising MCR-specific targeted peptides provide further opportunities for treating ocular (and systemic) inflammatory diseases. Following from these observations and a renewed clinical and pharmacological interest in the diverse biological roles of the melanocortin system, this review highlights the physiological and disease-related involvement of this system within human eye tissues. We also review the emerging benefits and versatility of melanocortin receptor targeted peptides as non-steroidal alternatives for inflammatory eye diseases such as non-infectious uveitis and dry eye disease, and translational applications in promoting ocular homeostasis, for example, in corneal transplantation and diabetic retinopathy.
引用
- Wu CS, Cioanca AV, Gelmi MC, et al. The multifunctional human ocular melanocortin system. Prog Retin Eye Res. 2023. PMID: 37217094. doi:10.1016/j.preteyeres.2023.101187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。